Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
BNCT Using B10 L-BPA in Malignant Brain Tumors
NCT07003139Phase 2Recruiting
- Sponsor
- China Medical University Hospital
- Start
- Jun 2025
- Primary completion
- Jun 2026
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of borofalan (10B) in brain tumor, sponsored by China Medical University Hospital. Started Jun 2025; status: recruiting.
02
Drugs
borofalan (10B)
03
Conditions
brain tumor
Beyond the preview
Go deeper on NCT07003139.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07003139.